SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $300,000 | +17.2% | 11,933 | -3.0% | 0.00% | -25.0% |
Q3 2020 | $256,000 | -22.7% | 12,296 | +22.9% | 0.00% | +100.0% |
Q2 2019 | $331,000 | -10.3% | 10,004 | -5.0% | 0.00% | -33.3% |
Q1 2019 | $369,000 | +12.5% | 10,532 | +6.8% | 0.00% | 0.0% |
Q4 2018 | $328,000 | -93.7% | 9,866 | -90.4% | 0.00% | -91.2% |
Q3 2018 | $5,169,000 | +1.6% | 102,660 | +20.8% | 0.03% | +3.0% |
Q2 2018 | $5,087,000 | +39.1% | 84,996 | +6.5% | 0.03% | +13.8% |
Q1 2018 | $3,656,000 | +37.9% | 79,829 | +20.0% | 0.03% | +61.1% |
Q4 2017 | $2,652,000 | +8.2% | 66,538 | +8.6% | 0.02% | +5.9% |
Q3 2017 | $2,451,000 | -11.9% | 61,275 | -5.0% | 0.02% | -10.5% |
Q2 2017 | $2,781,000 | +46.7% | 64,533 | +6.5% | 0.02% | +46.2% |
Q1 2017 | $1,896,000 | +13.3% | 60,583 | -8.6% | 0.01% | +8.3% |
Q4 2016 | $1,673,000 | -17.6% | 66,251 | -19.3% | 0.01% | -29.4% |
Q3 2016 | $2,031,000 | +43.6% | 82,110 | +18.3% | 0.02% | +30.8% |
Q2 2016 | $1,414,000 | +68.5% | 69,426 | +26.2% | 0.01% | +44.4% |
Q1 2016 | $839,000 | -30.0% | 55,019 | -38.3% | 0.01% | -25.0% |
Q4 2015 | $1,199,000 | -91.5% | 89,179 | -11.3% | 0.01% | -20.0% |
Q3 2015 | $14,109,000 | +1652.7% | 100,560 | +112.2% | 0.02% | +114.3% |
Q2 2015 | $805,000 | +213.2% | 47,390 | +122.8% | 0.01% | +250.0% |
Q1 2015 | $257,000 | – | 21,271 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |